This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
After a three-month evaluation of the RhodoLED XL, Aaron Hoover, MD, of Front Range Dermatology in Greeley,CO, was so impressed with its performance that his practice decided to purchase not one but two units, including the 100 th installed RhodoLED XL lamp. Market appeared first on The Dermatology Digest. Biofrontera Inc.
The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorization in Great Britain for delgocitinib cream (Anzupgo, Leo Pharma) for the treatment of adult patients with moderate to severe chronic hand eczema (CHE), for whom topical corticosteroids are inadequate or inappropriate.
“At Haut.AI, we primarily serve the B2B market, but we wanted to share SkinGPT’s groundbreaking capabilities with everyone,” says Anastasia Georgievskaya, CEO of Haut.AI, in a news release. Launches SkinGPT and Generative.Skin Library for Consumers appeared first on The Dermatology Digest.
immunology market.” Lebwohl, MD, Professor and Systemn Chaior of Dermatology at Icahn School of Medicine at Mount Sinai in New York, NY. FDA Approves Celltrion’s STELARA Biosimilar appeared first on The Dermatology Digest. Celltrion Inc. The post U.S.
The post-market clinical study will assess Cohealyxs performance in real-world settings, focusing on clinical efficacy and cost savings in the treatment of full-thickness wounds and burns. FDA Clears Avita Medicals Cohealyx for Healing Full-thickness Wounds appeared first on The Dermatology Digest. The post U.S.
for 10 grams of the mixture on par with sun blocks already on the market. 4c04969 The post Innovation in Action: This Prototype Sunscreen Protects and Cools Skin appeared first on The Dermatology Digest. C) cooler than bare skin, and up to 11.0 C) cooler than commercially available sunscreens.
We have also strategically prepared the platform for future expansion into new markets and clinical indications.” ” The post Non-invasive Skin Cancer Diagnostic Technology Update: SciBase Rolls Out the Next Generation of Nevisense appeared first on The Dermatology Digest.
The two companies will collaborate in sales, marketing, education, and research. market share within three years. market,” says Ethan Min, CEO of BENEV, in a news release. .” market,” says Ethan Min, CEO of BENEV, in a news release. “We Hugel Inc.’s s botulinum toxin product Letybo is coming to the U.S.
Gulf Coast, MS-based dermatologist Lindsey Zubritsky, MD, is all free clear ’s first-ever Chief Dermatology Advisor. Dr. Zubritsky will make her debut as Chief Dermatology Advisor for the all free clear brand on The View on May 8, 2024, at 11:00 a.m. .
The neuromodulator also has marketing authorization from Australia’s Therapeutic Goods Administration and the Medicines and Healthcare Products Regulatory Agency in the UK. The post Buoyed by New Data, Galdermas Liquid Toxin Launches Across Europe appeared first on The Dermatology Digest. In the U.S.,
Here’s what dermatology employers employees and other healthcare providers need to know: The new ban is slated to take effect in 120 days from April 23, 2024. The ban could affect employment decisions among people hiring or considering working for private or private-equity-backed dermatology practices.
.” The Unbeatable Performance campaign will feature Maher in a variety of content, including a modern recreation of the brand’s beloved girl-and-dog pose used on product packaging and in the brand’s marketing. The campaign will also include social media and online video.
market trends. Additionally, high-quality before and after photos enhance marketing efforts, attracting potential clients by demonstrating transformation. With nearly a century of combined experience in the aesthetic and marketing sectors, the Emage team offers unparalleled expertise and support to its clients.
Dr Godfrey Town presented a paper on “ EBD as home devices—effects and risks ” at the session “ Energy based devices: Body contouring and tightening ” and chaired the session “ Home-use devices HUD for acne—The Evidence ” where he presented a paper on “ Device market and regulation ”. Peter Bjerring, Prof. Moshe Lapidoth.
market,” says Ethan Min, Chief Executive Officer at BENEV, in a news release. “This partnership with Hugel allows us to strengthen our market position and fulfill our mission to BENefit EVeryone through transformative aesthetic solutions.” appeared first on The Dermatology Digest.
Cannabis-based personal care products suddenly seem ubiquitous all over the market, where CBD is a featured ingredient in everything from moisturizers and lotions to makeup.
The company has appointed Alex Haskell, MBA, as Vice President of Marketing, Sean Mathison as Vice President of Business Development & Innovation, Jonathan Nugent as Sales Director, and Olivia Swanson as Sales Director. In her new role, she will drive the expansion of (plated) Skin Science.
There are different types of specialties now doing treatments, whether it be nurse practitioners or general practitioners in certain markets. The post One-on-One: TDD/JDNPPA Goes Trend Spotting With Gerry Muhle, Galderma’s Head of Global Product Strategy appeared first on The Dermatology Digest.
In this episode, double board-certified dermatologist and experienced inventor Dr. Steven Hacker joins Lori to discuss his entrepreneurial journey, the role of estheticians in dermatology, and all things dermaplaning. Hacker, MD is a double board-certified dermatologist in both Dermatology and Mohs Surgery.
The acne market is changing, as consumers seek safer and more natural topical alternatives that offer faster results with low irritation. We have developed a product that we feel can help address that changing market need.” Jerry Tan and his vast knowledge to our team.
The dermatologymarket remains an exciting space with strong demand for its valuable services, bolstered by positive US economic trends and robust consumer spending.
By Lisette Hilton Instinctively, dermatologists might think it best to slow or stop practice marketing during pandemic shutdowns and through the uncertainty. Risa Goldman Luksa, Founder and President, Goldman Marketing Group “Marketing during this pandemic is extremely important.
The field of dermatology has certainly taken advantage of these innovative tools for laser dermatology treatments. Dermatology Partners Tyler, “Lasers are used to improve skin health and appearance in a variety of ways. Cleansing and Moisturizing Swelling isn’t the only side effect of laser dermatology treatment.
“With so many over the counter acne solutions on the market, the one brand I always trust and recommend is PanOxyl,” says Suneel Chilukuri, MD, Director of Cosmetic Surgery and Chief of Dermatology & Dermatologic Surgery at Refresh Dermatology in Houston, TX. PanOxyl was recommended 53.8%
Having a thorough understanding of the dermatology and plastic surgery procedures, in addition to all new and modern cosmetic procedures on the market, is critical in assisting your clients in answering questions.
Leo Pharma’s delgocitinib cream produces a deep, consistent, and/or maintained response in a subgroup of super-responders with moderate-to-severe Chronic Hand Eczema (CHE), according to a late-breaker presented at the American Academy of Dermatology’s 2025 Annual Meeting in Orlando, FL. At Week 16, 30.0%
This transaction is part of our strategy to continue supporting Galderma on its outstanding growth journey in the attractive dermatologymarket,” says Michael Bauer, Partner and Co-Head of the Global Healthcare Sector at EQT, in a news release. “We
Just days after snagging dual approvals for moderate-to-severe atopic dermatitis (AD) and prurigo nodularis (PN) in the European Union, nemolizumab (Nemluvio, Galderma) was also granted Marketing Authorization in the United Kingdom (UK) and Switzerland for AD and PN. Nemolizumab, an interleukin (IL)-31 inhibitor i s also approved by the U.S.
AVAVA’s groundbreaking Focal Point Technology has the potential to disrupt the energy-based device market like never before. The post Industry Vets Clint Carnell and Mary Fisher Join AVAVAs Board appeared first on The Dermatology Digest. I am excited to join AVAVA as Executive Chairman, says Mr. Carnell.
SpringWorks Marketing Authorization Application for mirdametinib for the treatment of children and adults with NF1-PN was validated by the European Medicines Agency (EMA) and is currently under review; a decision is expected from the European Commission in 2025. The post U.S
These benefits include assistance in the drug development process, tax credits for qualified clinical costs, exemptions from certain FDA fees, and seven years of marketing exclusivity. FDA Grants Orphan Drug Designation for Restem’s ULSC Program for the Treatment of Dermatomyositis and Polymyositis appeared first on The Dermatology Digest.
Several new therapies are coming down the pike for the treatment of lichen planus, a chronic inflammatory condition that affects an estimated 1% to 2% of the global population, according to a new report from Research and Markets. Stay tuned.
Learn more about the different marketing terms used in skin care and what they really mean. People tend to assume natural fragrances are better than synthetic ones, but I think a lot of this has to do with the increased popularity of “clean” beauty marketing. What is Fragrance? The short answer is no.
Most recently, she was Managing Director at Eurazeo Brands, a mid-market private equity firm. I look forward to collaborating with the leadership team and contributing to the company’s continued growth and success in the global skincare market.” “We are thrilled to welcome Ms.
People with primary hyperhidrosis are more likely to have sensitive skin, a new study in the Journal of the Drugs and Dermatology suggests. The post Excessive Sweating, Sensitive Skin Linked appeared first on The Dermatology Digest.
Food and Drug Administration (FDA) and Marketing Authorization Application (MAA) in the UK and EU for CORDStrom in Recessive Dystrophic Epidermolysis Bullosa (RDEB). This trial showed a favorable benefit-risk profile in support of the intended applications for marketing authorization. INmune Bio, Inc.
The deal strengthens Cosettes dermatology and womens health businesses, expands Cosettes commercial and operational capabilities, and adds multiple sustainable and growing patent-protected products. The post Cosette Pharmaceuticals Acquires Mayne Pharma appeared first on The Dermatology Digest.
approved by the EC, the Company expects to market B-VEC under the registered European trademark, Vyjuvek. The post EMAs CHMP Recommends Krystals Vyjuvek for Dystrophic Epidermolysis Bullosa appeared first on The Dermatology Digest.
Whitney Bowe discusses branding and marketing pearls, including real-life anecdotes and experiences as well as best practices for developing and sustaining social media content and engagement. Whitney Bowe, MD, FAAD, Advanced Dermatology, PC, Briarcliff Manor, NY. “I’m branding is that emotional response.
To gauge the impact and evolving landscape of HS treatment post-secukinumab approval, Spherix Global Insights conducted research with more than 100 US dermatologists.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content